Amulet™ ADVANCE LAA

Running, not enrolling

Conditions studied: Atrial Fibrillation, Stroke, Bleeding

In brief

This is a prospective, multicenter, observational study intended to characterize real-world outcomes on the commercially available Amulet device in the United States. Over 600 subjects have been enrolled at 16 US clinical sites. Subjects will be followed through 24 months in accordance with each site's standard care practices.

Key facts

Study ID
NCT05997446
Run by
Abbott Medical Devices
People needed
610
Starts
2023-07-12
Expected to finish
2027-06-01
Last updated by the study team
2025-10-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.